Home/Filings/4/0001209191-16-102577
4//SEC Filing

Endo International plc 4

Accession 0001209191-16-102577

CIK 0001593034operating

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 8:15 PM ET

Size

14.4 KB

Accession

0001209191-16-102577

Insider Transaction Report

Form 4
Period: 2016-02-23
DE SILVA RAJIV
DirectorPresident & CEO
Transactions
  • Award

    Stock Incentive Plan Performance Shares

    2016-02-23+149,342468,766 total
  • Award

    2015 Stock Incentive Plan Stock Options (NQ)

    2016-02-23+167,897167,897 total
    Exercise: $50.22Exp: 2026-02-23Ordinary Shares (167,897 underlying)
Holdings
  • Ordinary Shares

    181,380
  • Ordinary Shares

    (indirect: By Trust)
    63,315
Footnotes (6)
  • [F1]The performance shares vest upon Endo International plc achieving certain shareholder return performance metrics over a cumulative three-year period.
  • [F2]Represents the target number of shares issuable upon Endo International plc's achievement of shareholder return performance metrics over a cumulative three-year period, as determined by Endo International plc's Board of Directors at the end of such three-year period. The ultimate number of shares issued may be between 0% and 300% of the target number of shares, depending on Endo International plc's shareholder return performance metrics results over the performance period.
  • [F3]These securities were granted to Mr. De Silva in consideration of his services as the President and Chief Executive Officer of Endo International plc.
  • [F4]Represents the cumulative target number of shares issuable with respect to all 2010 Stock Incentive Plan and 2015 Stock Incentive Plan performance shares outstanding. The cumulative total is the combination of the target payouts for the current grant and all past grants made under the 2010 Stock Incentive Plan and 2015 Stock Incentive Plan and still outstanding, which are subject to a range of payouts depending on Endo International plc's achievement of certain performance metrics as described herein for the current grants and as previously disclosed for all other performance share grants.
  • [F5]Represents the right to buy ordinary shares, par value $0.0001 per share, of Endo International plc.
  • [F6]These stock options are generally exercisable 25% per year on each of February 23, 2017, February 23, 2018, February 23, 2019 and February 23, 2020.

Issuer

Endo International plc

CIK 0001593034

Entity typeoperating

Related Parties

1
  • filerCIK 0001593034

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 8:15 PM ET
Size
14.4 KB